Severity assessment of skin and soft tissue infections: cohort study of management and outcomes for hospitalized patients
Open Access
- 5 October 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 66 (2), 387-397
- https://doi.org/10.1093/jac/dkq362
Abstract
BackgroundSkin and soft tissue infections (SSTIs) are caused by bacterial invasion of the skin and underlying soft tissues and can present with a wide spectrum of signs, symptoms and illness severity. They are a common indication for antimicrobial therapy. However, there are few data on treatment outcomes or the validity of clinical severity scores.MethodsTwo hundred and five adult patients admitted to Ninewells Hospital, Scotland in 2005, and treated with antibiotics for SSTI, were identified. They were stratified into four classes of severity (class IV = most severe) based on sepsis, co-morbidity and their standardized early warning score (SEWS). Empirical antimicrobial therapy by severity class was compared with the recommendations of a UK guideline.ResultsThirty-five different empirical antimicrobial regimens were prescribed. Overall, 43% of patients were over-treated, this being particularly common in the lowest severity class I (65% patients). Thirty-day mortality was 9% (18/205) and 17 patients (8%) died during their index admission. Mortality (30 day) and inadequate therapy increased with severity class: I, no sepsis or co-morbidity (45% patients, 1% mortality, 14% therapy inadequate); II, significant co-morbidity but no sepsis (32% patients, 11% mortality, 39% therapy inadequate); III, sepsis but SEWS <4 (17% of patients, 17% mortality, 39% therapy inadequate); and IV, sepsis plus SEWS ≥4 (6% of patients, 33% mortality, 92% therapy inadequate).ConclusionsSSTI in hospital is associated with significant mortality. Choice of empirical therapy is not evidence based, with significant under-treatment of severely ill patients.Keywords
This publication has 29 references indexed in Scilit:
- The European Surveillance of Antimicrobial Consumption (ESAC) Point‐Prevalence Survey of Antibacterial Use in 20 European Hospitals in 2006Clinical Infectious Diseases, 2009
- Clinical and Economic Consequences of Failure of Initial Antibiotic Therapy for Hospitalized Patients With Complicated Skin and Skin-Structure InfectionsInfection Control & Hospital Epidemiology, 2008
- Bacterial Skin and Soft Tissue Infections in Adults: A Review of Their Epidemiology, Pathogenesis, Diagnosis, Treatment and Site Of CareCanadian Journal of Infectious Diseases and Medical Microbiology, 2008
- Practice Guidelines for the Diagnosis and Management of Skin and Soft-Tissue InfectionsClinical Infectious Diseases, 2005
- The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: A tool for distinguishing necrotizing fasciitis from other soft tissue infections*Critical Care Medicine, 2004
- Objective criteria may assist in distinguishing necrotizing fasciitis from nonnecrotizing soft tissue infectionThe American Journal of Surgery, 2000
- A Prediction Rule to Identify Low-Risk Patients with Community-Acquired PneumoniaNew England Journal of Medicine, 1997
- Necrotizing Soft Tissue InfectionsAnnals of Surgery, 1996
- Erysipelas: Clinical and Bacteriologic Spectrum and Serological AspectsClinical Infectious Diseases, 1996
- Necrotizing Soft-Tissue InfectionsArchives of Surgery, 1996